Dendritic cell vaccination for glioblastoma multiforme: review with focus on predictive factors for treatment response

Glioblastoma multiforme (GBM) is the most common and most aggressive type of primary brain cancer. Since median overall survival with multimodal standard therapy is only 15 months, there is a clear need for additional effective and long-lasting treatments. Dendritic cell (DC) vaccination is an exper...

Ausführliche Beschreibung

Bibliographische Detailangaben
Hauptverfasser: Dejaegher, Joost, Van Gool, Stefaan, De Vleeschouwer, Steven
Format: Online Artikel Text
Sprache:English
Veröffentlicht: Dove Medical Press 2014
Schlagworte:
Review
Online Zugang:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4918234/
https://www.ncbi.nlm.nih.gov/pubmed/27471700
http://dx.doi.org/10.2147/ITT.S40121

Online

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4918234/
https://www.ncbi.nlm.nih.gov/pubmed/27471700
http://dx.doi.org/10.2147/ITT.S40121

Ähnliche Einträge